SCHEMBL26720231

SCHEMBL26720231

Fc1ccc(-c2nn3c(c2Br)COCC3)nc1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CSNK1D P48730 10/20 0.57
MAPK14 Q16539 3/20 0.56
THRB P10828 2/20 0.40
TGFBR1 P36897 1/20 0.40
SIGMAR1 Q99720 2/20 0.36
CSNK1A1 P48729 2/20 0.36
CSNK1E P49674 2/20 0.36
TNIK Q9UKE5 2/20 0.36
HTR1A P08908 1/20 0.36
DRD3 P35462 1/20 0.36
SLC6A3 Q01959 1/20 0.36
ACVR1 Q04771 2/20 0.33
GABRA5 P31644 1/20 0.33
ATR Q13535 1/20 0.32
ATRIP Q8WXE1 1/20 0.32
GRM5 P41594 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2524313 0.81 CSNK1D (0.48) CSNK1DMAPK14THRBTGFBR1CSNK1E
SCHEMBL24348532 0.80 TGFBR1 (0.56) CSNK1DMAPK14THRBTGFBR1CSNK1A1
SCHEMBL30403321 0.80 CSNK1D (0.63) CSNK1DMAPK14THRBTGFBR1CSNK1A1
SCHEMBL26720854 0.80 CSNK1D (0.63) CSNK1DMAPK14THRBTGFBR1CSNK1A1
SCHEMBL26720251 0.79 CSNK1D (0.54) CSNK1DMAPK14THRBTGFBR1CSNK1A1
SCHEMBL26720525 0.78 CSNK1D (0.44) CSNK1DMAPK14THRBTGFBR1SIGMAR1
SCHEMBL26720311 0.77 SIGMAR1 (0.39) CSNK1DMAPK14THRBTGFBR1SIGMAR1
SCHEMBL29514461 0.77 SIGMAR1 (0.39) CSNK1DMAPK14THRBTGFBR1SIGMAR1
SCHEMBL26720313 0.77 SIGMAR1 (0.39) CSNK1DMAPK14THRBTGFBR1SIGMAR1
SCHEMBL26720315 0.77 SIGMAR1 (0.39) CSNK1DMAPK14THRBTGFBR1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339970-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
US-20230339970-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
US-20230339970-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
EP-4214214-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN Pharmaceutica NV (BE) 2023-07-26 EP disclosed
CN-116171280-A Casein kinase 1 delta modulators 詹森药业有限公司 2023-05-26 CN disclosed
WO-2022058920-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2022-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339970-A1 CASEIN KINASE 1 DELTA MODULATORS CSNK1D, CSNK1A1, CSNK1G1 CSNK1D 1/4885MAPK14 453/4885THRB 493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.